Jahanvi Miller
JahvanMed Advisors
CEO & Founder
Bridging Regulatory & Continuous Improvement Gaps for End to End Quality & Operational Excellence ®
CEO and Founder Jahanvi Miller has spent over 25 years in Life Sciences shaping quality organizations in large pharmaceutical and device companies such as Johnson & Johnson, Amgen, Otsuka, and Baxter. As the former Head of Global Quality External Affairs, Strategy & Business Operations for Baxter, Janie led many best practice development and implementation strategies within the organization, in addition to leading multiple industry efforts. She joined Baxter with extensive experience from Amgen GQC (Global Quality Compliance) where she was the lead for activities within the Americas (North, Central & South), in addition to Canada, China, and Singapore. She was a conjugate in developing and shaping global policy/regulations which are consistent with industry best practices. Janie was also the internal lead on competitive intelligence reporting into corporate leadership teams to gain early access to new markets.
As the lead for Amgen’s annual GMP training she ensured that global teams were enabled with the right knowledge and tools to produce high quality medicines. She also developed several aseptic, supply chain, quality risk management (QRM) and manufacturing science trainings for the Parenteral Drug Association (PDA) during her tenure at PDA.
Many of her experiences integrate quality centric approaches which enable operational excellence. She also engages with internal and external stakeholders to meet and implement global regulatory expectations throughout the product life cycle and frameworks to meet industry standards (such as ISO 9001 and GMPs) to ensure product safety and regulatory compliance (incl. early warning signals for proactive compliance and effective quality systems).
She has a deep understanding of regulatory requirements, technology and innovation, in addition to business sustainability.
She is currently an active contributor to these industry initiatives:
• ISPE Chair of Regulatory and Quality Committee- Biotech CoP • ISPE 2026 Annual Meeting Committee Member • ISPE CBA Advisory Council
• ISPE 2026 Annual Meeting WIP Workshop Chair
• ISPE Women In Pharma Steering Committee
• ISPE Chapter Chair Good Practice Guide Quality 4.0
• ISPE Chapter Chair Continuous Manufacture of Biotech Good Practice Guide
Former Industry Initiatives:
• PhRMA – Chair of Quality Workstream
• ISPE BioTech Keynote Panel Speaker
CEO and Founder Jahanvi Miller has spent over 25 years in Life Sciences shaping quality organizations in large pharmaceutical and device companies such as Johnson & Johnson, Amgen, Otsuka, and Baxter. As the former Head of Global Quality External Affairs, Strategy & Business Operations for Baxter, Janie led many best practice development and implementation strategies within the organization, in addition to leading multiple industry efforts. She joined Baxter with extensive experience from Amgen GQC (Global Quality Compliance) where she was the lead for activities within the Americas (North, Central & South), in addition to Canada, China, and Singapore. She was a conjugate in developing and shaping global policy/regulations which are consistent with industry best practices. Janie was also the internal lead on competitive intelligence reporting into corporate leadership teams to gain early access to new markets.
As the lead for Amgen’s annual GMP training she ensured that global teams were enabled with the right knowledge and tools to produce high quality medicines. She also developed several aseptic, supply chain, quality risk management (QRM) and manufacturing science trainings for the Parenteral Drug Association (PDA) during her tenure at PDA.
Many of her experiences integrate quality centric approaches which enable operational excellence. She also engages with internal and external stakeholders to meet and implement global regulatory expectations throughout the product life cycle and frameworks to meet industry standards (such as ISO 9001 and GMPs) to ensure product safety and regulatory compliance (incl. early warning signals for proactive compliance and effective quality systems).
She has a deep understanding of regulatory requirements, technology and innovation, in addition to business sustainability.
She is currently an active contributor to these industry initiatives:
• ISPE Chair of Regulatory and Quality Committee- Biotech CoP • ISPE 2026 Annual Meeting Committee Member • ISPE CBA Advisory Council
• ISPE 2026 Annual Meeting WIP Workshop Chair
• ISPE Women In Pharma Steering Committee
• ISPE Chapter Chair Good Practice Guide Quality 4.0
• ISPE Chapter Chair Continuous Manufacture of Biotech Good Practice Guide
Former Industry Initiatives:
• PhRMA – Chair of Quality Workstream
• ISPE BioTech Keynote Panel Speaker